idiopathic hypersomnia/fatigue

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

7 niðurstöður

Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVE To characterize the clinical, psychological, and sleep pattern of idiopathic hypersomnia with and without long sleep time, and provide normative values for 24-hour polysomnography. METHODS University Hospital. METHODS Controlled, prospective cohort. METHODS 75 consecutive patients (aged 34

How significant are primary sleep disorders and sleepiness in the chronic fatigue syndrome?

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

In order to study both the prevalence of Primary Sleep Disorders (PSD) and sleepiness, and their association to the Chronic Fatigue Syndrome (CFS), 46 unselected outpatients (34 women, mean age 36.5) were examined clinically and underwent two nights of all-night polysomnography and multiple sleep

Systemic exertion intolerance disease/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Symptoms of the central disorders of hypersomnolence extend beyond excessive daytime sleepiness to include non-restorative sleep, fatigue and cognitive dysfunction. They share much in common with myalgic encephalomyelitis/chronic fatigue syndrome, recently renamed systemic exertion intolerance

Modafinil: the unique properties of a new stimulant.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Modafinil, a novel stimulant which has several remarkable features that distinguish it from other stimulants, has been developed by Lafon, a French pharmaceutical company. Unlike the amphetamines, for example, modafinil is reported to have minimal peripheral side effects at therapeutic doses. It

[Narcolepsy and Other 'Central Disorders of Hypersomnolence'].

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Narcolepsy and Other 'Central Disorders of Hypersomnolence' Abstract. 'Excessive daytime sleepiness', 'hypersomnia' in the sense of prolonged sleep need, 'tiredness' or 'fatigue' are frequent complaints in primary care, requiring a careful separation in view of a correct diagnostic. After exclusion

The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The aim of the current study was to evaluate an attention test as a discriminative tool to measure neurocognitive impairment in patients with disorders of hypersomnolence. Chronic excessive daytime sleepiness is the main symptom in central disorders of hypersomnolence. For diagnostic purposes and

Relationship of rare disorder latent clusters to anxiety and depression symptoms.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

A single rare disorder or disease (RD) affects fewer than 200,000 Americans. Combined, RDs affect 30 million Americans. Collectively, people with RDs have higher levels of anxiety and depression compared with those with prevalent diseases. Previous attempts to study psychological

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum